Rockefeller Capital Management’s Integra LifeSciences IART Stock Holding History

Rockefeller Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5K	Sell	751 -340	-31%	-$4.75K	﹤0.01%	3892
2026 Q1	$10.3K	Sell	1,091 -588	-35%	-$6.46K	﹤0.01%	3981
2025 Q4	$20.9K	Buy	1,679 +1,492	+798%	+$19.8K	﹤0.01%	3500
2025 Q3	$2.68K	Buy	+187	New	+$2.56K	﹤0.01%	4033
2023 Q1	–	Sell	-382	Closed	-$21K	–	2866
2022 Q4	$21K	Buy	382 +15	+4%	+$763	﹤0.01%	2781
2022 Q3	$15K	Buy	367 +123	+50%	+$6.3K	﹤0.01%	2898
2022 Q2	$13K	Buy	244 +148	+154%	+$8.89K	﹤0.01%	2983
2022 Q1	$6K	Buy	+96	New	+$6.32K	﹤0.01%	3275
2021 Q4	–	Sell	-24	Closed	-$1K	–	3867
2021 Q3	$1K	Buy	+24	New	+$1.7K	﹤0.01%	3577
2020 Q3	–	Sell	-53	Closed	-$2K	–	2674
2020 Q2	$2K	Buy	+53	New	+$2.6K	﹤0.01%	2327
2019 Q2	–	Sell	-375	Closed	-$21K	–	1795
2019 Q1	$21K	Buy	+375	New	+$19.1K	﹤0.01%	1212

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Rockefeller Capital Management's IART Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Integra LifeSciences (IART) stake by 31% in Q2 2026, selling an estimated $4.75K and leaving 751 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3892.

Rockefeller Capital Management first reported a position in IART in Q1 2019 and has held it in 11 quarters since. The position peaked at $21K in Q4 2022. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Rockefeller Capital Management held 751 shares of Integra LifeSciences worth $13.5K as of Q2 2026.
Rockefeller Capital Management sold 340 Integra LifeSciences shares in Q2 2026, an estimated $4.75K.
Integra LifeSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3892 holding.
Rockefeller Capital Management first reported a position in Integra LifeSciences in Q1 2019 and has held it in 11 quarters since.
Rockefeller Capital Management's Integra LifeSciences position peaked at $21K in Q4 2022.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.